1. 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial. Issue 10191 (29th June 2019) Authors: Piprot, C; Cals, L; Chaigneau, L; Demarchi, F; N'Guyen, T; Stein, U; Villanueva, C; Bréau, JL; Chouahnia, AK; Saintigny, P; Boué, F; deSaint-Hilaire, P; Guimont, I; Grossat, N; Valenza, B; Lévy, E; Médioni, J; Delbaldo, C; Grenier, J; Pouessel, D Journal: Lancet Issue: Volume 393:Issue 10191(2019) Page Start: 2591 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial. Issue 10191 (29th June 2019) Authors: Pivot, Xavier; Romieu, Gilles; Debled, Marc; Pierga, Jean-Yves; Kerbrat, Pierre; Bachelot, Thomas; Lortholary, Alain; Espié, Marc; Fumoleau, Pierre; Serin, Daniel; Jacquin, Jean-Philippe; Jouannaud, Christelle; Rios, Maria; Abadie-Lacourtoisie, Sophie; Venat-Bouvet, Laurence; Cany, Laurent; Catal... Journal: Lancet Issue: Volume 393:Issue 10191(2019) Page Start: 2591 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A European Organisation for Research and Treatment of Cancer randomized, double-blind, placebo-controlled, multicentre phase II trial of anastrozole in combination with gefitinib or placebo in hormone receptor-positive advanced breast cancer (NCT00066378). (January 2016) Authors: Tryfonidis, Konstantinos; Basaran, Gul; Bogaerts, Jan; Debled, Marc; Dirix, Luc; Thery, Jean-Christophe; Tjan-Heijnen, Vivianne C.G.; Van den Weyngaert, Danielle; Cufer, Tanja; Piccart, Martine; Cameron, David Journal: European journal of cancer Issue: Volume 53(2016) Page Start: 144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Assessment of the efficacy of successive endocrine therapies in hormone receptor–positive and HER2-negative metastatic breast cancer: a real-life multicentre national study. (September 2019) Authors: Le Saux, Olivia; Lardy-Cleaud, Audrey; Frank, Sophie; Debled, Marc; Cottu, Paul H.; Pistilli, Barbara; Vanlemmens, Laurence; Leheurteur, Marianne; Lévy, Christelle; Laborde, Lilian; Uwer, Lionel; D'hondt, Veronique; Berchery, Delphine; Lorgis, Veronique; Ferrero, Jean-Marc; Perrocheau, Genevieve;... Journal: European journal of cancer Issue: Volume 118(2019) Page Start: 131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinicopathological characteristics and prognosis of breast cancer patients with isolated central nervous system metastases in the multicentre ESME database. (February 2022) Authors: Carausu, Marcela; Carton, Matthieu; Cabel, Luc; Patsouris, Anne; Levy, Christelle; Verret, Benjamin; Pasquier, David; Debled, Marc; Gonçalves, Anthony; Desmoulins, Isabelle; Lecouillard, Isabelle; Bachelot, Thomas; Ferrero, Jean-Marc; Eymard, Jean-Christophe; Mouret-Reynier, Marie-Ange; Chevrot, ... Journal: Therapeutic advances in medical oncology Issue: Volume 14(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Complete response to exemestane in a patient with a desmoid tumor. (April 2012) Authors: Debled, Marc; Le Loarer, François; Callonnec, Françoise; Soubeyran, Isabelle; Cambon-Michot, Chantal; Dujardin, Franck; Italiano, Antoine Journal: Future oncology Issue: Volume 8:Number 4(2012) Page Start: 483 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Comprehensive analysis of PTEN status in breast carcinomas. Issue 2 (12th February 2013) Authors: Jones, Natalie; Bonnet, Françoise; Sfar, Sana; Lafitte, Marie; Lafon, Delfine; Sierankowski, Ghislaine; Brouste, Véronique; Banneau, Guillaume; Tunon de Lara, Christine; Debled, Marc; MacGrogan, Gaëtan; Longy, Michel; Sevenet, Nicolas Journal: International journal of cancer Issue: Volume 133:Issue 2(2013:Jul. 15) Page Start: 323 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Contemporary outcomes of metastatic breast cancer among 22, 000 women from the multicentre ESME cohort 2008–2016. (April 2020) Authors: Deluche, Elise; Antoine, Alison; Bachelot, Thomas; Lardy-Cleaud, Audrey; Dieras, Veronique; Brain, Etienne; Debled, Marc; Jacot, William; Mouret-Reynier, Marie Ange; Goncalves, Anthony; Dalenc, Florence; Patsouris, Anne; Ferrero, Jean Marc; Levy, Christelle; Lorgis, Veronique; Vanlemmens, Laurenc... Journal: European journal of cancer Issue: Volume 129(2020) Page Start: 60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Deprivation and mass screening: Survival of women diagnosed with breast cancer in France from 2008 to 2010. (June 2019) Authors: Poiseuil, Marie; Coureau, Gaëlle; Payet, Catherine; Savès, Marianne; Debled, Marc; Mathoulin-Pelissier, Simone; Amadeo, Brice Journal: Cancer epidemiology Issue: Volume 60(2019:Jun.) Page Start: 149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy of taxanes rechallenge in first-line treatment of early metastatic relapse of patients with HER2-negative breast cancer previously treated with a (neo)adjuvant taxanes regimen: A multicentre retrospective observational study. (October 2022) Authors: Vasseur, Antoine; Carton, Matthieu; Guiu, Severine; Augereau, Paule; Uwer, Lionel; Mouret-Reynier, Marie-Ange; Levy, Christelle; Eymard, Jean-Christophe; Ferrero, Jean-Marc; Leheurteur, Marianne; Goncalves, Anthony; Robert, Marie; De La Motte Rouge, Thibault; Bachelot, Thomas; Petit, Thierry; Deb... Journal: Breast Issue: Volume 65(2022) Page Start: 136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗